SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-031263
Filing Date
2023-03-10
Accepted
2023-03-10 17:03:47
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm239199d1_8k.htm   iXBRL 8-K 23410
  Complete submission text file 0001104659-23-031263.txt   198615

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20230310.xsd EX-101.SCH 3057
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20230310_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20230310_pre.xml EX-101.PRE 22611
6 EXTRACTED XBRL INSTANCE DOCUMENT tm239199d1_8k_htm.xml XML 3725
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 23724587
SIC: 2834 Pharmaceutical Preparations